First trimester fetal nuchal translucency
Copyright policy )First trimester fetal nuchal translucency
This review examines the development of a new method of screening for Down's syndrome based on the combination of fetal nuchal translucency thickness, maternal age and maternal serum biochemistry at 10-14 weeks of gestation. This method can potentially identify more than 80% of affected fetuses for a false-positive rate of less than 5%.
- University of Cambridge United Kingdom
- Harris Birthright Research Centre for Fetal Medicine United Kingdom
Chromosome Aberrations, Chromosome Disorders, Chorionic Gonadotropin, Sensitivity and Specificity, Peptide Fragments, Ultrasonography, Prenatal, Pregnancy Trimester, First, Pregnancy, Prenatal Diagnosis, Humans, Pregnancy-Associated Plasma Protein-A, Chorionic Gonadotropin, beta Subunit, Human, Female, Down Syndrome, Neck, Maternal Age
Chromosome Aberrations, Chromosome Disorders, Chorionic Gonadotropin, Sensitivity and Specificity, Peptide Fragments, Ultrasonography, Prenatal, Pregnancy Trimester, First, Pregnancy, Prenatal Diagnosis, Humans, Pregnancy-Associated Plasma Protein-A, Chorionic Gonadotropin, beta Subunit, Human, Female, Down Syndrome, Neck, Maternal Age
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).43 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!